Metabolic-Associated Fatty Liver Disease and Sarcopenia
Endocrinology and Metabolism Clinics of North America · 2023-09 · 52 (3) · 497-508
DOI: 10.1016/j.ecl.2023.02.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrinology and Metabolism Clinics of North America, 2023-09. Verfasst von Triada Bali und 2 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Internal Medicine, General Hospital of Athens "Laiko", Medical School of National and Kapodistrian University of Athens, 17 Agiou…. Hauptthemen laut MEDLINE: Sarcopenia, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 70 Literaturangaben.
Abstract (Originalsprache)
The current evidence indicates a strong association between sarcopenia, the loss of muscle mass and strength, and metabolic-associated fatty liver disease (MAFLD). The two entities share many common pathophysiologic mechanisms, and their coexistence may result in higher rates of morbidity and mortality. Therefore, given their increasing incidence in the modern world, there is a need for a better understanding of the liver-muscle axis for early identification of sarcopenia in patients with MAFLD and vice versa. This review aims at presenting current data regarding the correlation between sarcopenia and MAFLD, the associated comorbidities, and the need for effective therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First Department of Internal Medicine, General Hospital of Athens "Laiko", Medical School of National and Kapodistrian University of Athens, 17 Agiou Thoma Street, Athens 11527, Greece.
- First Department of Internal Medicine, General Hospital of Athens "Laiko", Medical School of National and Kapodistrian University of Athens, 17 Agiou Thoma Street, Athens 11527, Greece. Electronic address: cholongitas@y…
Zitieren
APA
Bali, T., Chrysavgis, L., & Cholongitas, E. (2023). Metabolic-Associated Fatty Liver Disease and Sarcopenia. Endocrinology and Metabolism Clinics of North America, 52(3), 497-508. https://doi.org/10.1016/j.ecl.2023.02.004
Vancouver
Bali T, Chrysavgis L, Cholongitas E. Metabolic-Associated Fatty Liver Disease and Sarcopenia. Endocrinology and Metabolism Clinics of North America. 2023;52(3):497-508. doi:10.1016/j.ecl.2023.02.004
BibTeX
@article{Bali2023,
author = {Bali, Triada and Chrysavgis, Lampros and Cholongitas, Evangelos},
title = {Metabolic-Associated Fatty Liver Disease and Sarcopenia},
journal = {Endocrinology and Metabolism Clinics of North America},
year = {2023},
volume = {52},
number = {3},
pages = {497--508},
doi = {10.1016/j.ecl.2023.02.004}
}
EUVIMED